Trials / Unknown
UnknownNCT05643352
Barbed Reposition Pharyngoplasty in Patients Complaining of Unilevel Palatal Snoring
Patient-reported Outcomes of Barbed Reposition Pharyngoplasty in Unilevel Palatal Snoring: a Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- AZ Delta · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine whether there is a statistically significant difference in snoring intensity before and after performing a Barbed Reposition Pharyngoplasty as a single-level snoring procedure. The investigators aim to determine whether this is a valid alternative to the more classical techniques of pharyngoplasty. Furthermore, the investigators also wish to map the various postoperative complications and compare them with those of the more conventional techniques. The investigators compare the snoring intensity before surgery with the snoring intensity at 2 weeks (first postoperative control), at 6 weeks (second postoperative control) and at 6 months (Third postoperative control). For the evaluation of snoring, the investigators use 4 scales/questionnaires. These questionnaires are currently also used as standard at the outpatient clinic for snoring problems. These 4 scales/questionnaires are completed at every check-up. During the first postoperative check-up, the postoperative side effects are checked (bleeding, infection, readmission, needed consultation with another doctor, date of resumption of work). The investigators also map the pain with a visual analog scale and measure this the day after the operation and let the patient fill it in 3 days, 1 week and 2 weeks after the operation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Barbed reposition pharyngoplasty | Barbed reposition pharyngoplasty was performed in all patients |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2022-12-01
- Completion
- 2023-02-01
- First posted
- 2022-12-08
- Last updated
- 2022-12-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05643352. Inclusion in this directory is not an endorsement.